Biogen Shares Down After Q4 Earnings, 2017 Weak Outlook

From StockNews.com: Biogen Inc (NASDAQ:BIIB) early Thursday posted mixed fourth quarter earnings results and offered a tepid 2017 outlook that sent its shares plunging.
NASDAQ:BIIB January 26, 2017 7:17am

Biogen Shares Hammered On Ely Lilly’s Drug Failure

Biogen Inc (NASDAQ:BIIB) shares were down up to 8% in early trading Wednesday, as investors sold the biotech’s stock following a major competitor’s drug failure.
NASDAQ:BIIB November 23, 2016 8:15am

What Price Could Biogen be Acquired For?

Yesterday’s rumored M&A interest in Biogen Inc (NASDAQ:BIIB) spiked the stock 10% in a single day. Now that the euphoria has died down, let’s examine what a realistic takeover number might be.
NASDAQ:BIIB August 3, 2016 12:50pm

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

From Our Partners

7 Safe Haven Dividend Stocks for Turbulent Times

Most Popular



Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories